Navigation Links
Sirion Therapeutics Supports Ophthalmic Education
Date:9/28/2007

- Company Provides Unrestricted Educational Grants to Support the 25th

Biennial Cornea Research Conference and the Inaugural DIRECT Dry AMD

Meeting -

TAMPA, Fla., Sept. 28 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, today announced its support of the advancement of ocular innovation through its contributions of unrestricted educational grants to two upcoming ophthalmology conferences.

The first conference is Harvard University's Schepens Eye Research Institute's 25th Biennial Cornea Research Conference, taking place October 12 and 13, 2007 in Boston, MA. Schepens is the largest independent eye research institute in the nation, and an affiliate of Harvard Medical School. For additional information on this meeting, please visit their website at http://www.schepens.harvard.edu/cornea07.htm.

The second contribution will benefit the Duke University School of Medicine's Inaugural DIRECT Dry AMD Meeting, taking place October 25-27, 2007 in Durham, NC. This conference will update attendees with the latest information on Dry Age-related Macular Degeneration (AMD). For additional information on this meeting, please visit their website at http://www.directamd.com.

"Both of these conferences play a vital role in the awareness and advancement of research in ophthalmology," said Barry Butler, Sirion's President and Chief Executive Officer. "We appreciate the opportunity to support these institutions in advancing the treatment of ophthalmic disease."

About Sirion Therapeutics, Inc.

Sirion Therapeutics is a privately held biopharmaceutical company pursuing the discovery, development and commercialization of products addressing unmet medical needs in the protection and preservation of eyesight. Sirion's pipeline includes four late-stage opportunities: ganciclovir, a topical antiviral for herpetic keratitis which is awaiting an NDA filing in early 2008; difluprednate, a potent topical steroid in Phase III development for post-operative inflammation and uveitis; cyclosporine, a topical immunomodulator in Phase III testing for dry eye and fenretinide, a first-in-class oral vitamin A binding protein antagonist in Phase II development for geographic atrophy associated with dry AMD. For more information regarding Sirion, please visit Sirion's website at http://www.siriontherapeutics.com.


'/>"/>
SOURCE Sirion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. CDW buyer supports Berbee growth plans
3. Tech center supports energy-saving device for heat-treating plants
4. Inacom Supports Blackhawk Technology Mentor Program
5. Computer Card Supports Solo Doctor
6. Federal Funding Supports Small Business Innovation
7. Doyle urges support of higher education spending
8. Jump starting technology education
9. Stem cell and regenerative medicine center to aid education and commerce
10. Education is fundamental to Milwaukees growth
11. New book touts educational power of computer games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... 15, 2017 , ... JULABO USA introduces its new website ... makes it easy to navigate through the site whether you’re in the office, ... information, educational industry content and visit the company’s social media accounts, all on ...
(Date:8/11/2017)... ... August 11, 2017 , ... A staple in the community for more than ... important key elements including a new digital marketing strategy and updated logo. , As ... Miller has partnered with the South Texas Blood & Tissue Center for the month ...
(Date:8/10/2017)... Yorba Linda, Ca (PRWEB) , ... August 09, ... ... and exosomes for regenerative medicine applications in the clinic is here. The team ... secreted EVs present in conditioned medium for clinical studies. , Dr. Travis ...
(Date:8/10/2017)... USA, and CARDIFF, UK (PRWEB) , ... August ... ... and photonics, has announced an agreement establishing Kinokuniya Company Ltd. as its exclusive ... SPIE as the exclusive sales representative for the SPIE Digital Library in Japan. ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):